RxDoctor Payments Data

Emilie Long, APRN

Women's Health · Lincoln, NENPI 1558015032

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 25.8% of the total.

$937in general payments, 2019–2025

Across 48 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$242
  • Sumitomo Pharma America, Inc.$138
  • Mayne Pharma Commercial LLC$122
  • Daiichi Sankyo Inc.$85
  • Organon$85
  • Coopersurgical, Inc.$66
  • plus $198 from 9 others

What the payments were for

  • Food & beverage$937100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$937 in reported general payments places this provider in the 60th percentile of 60 women's health providers in Nebraska.

See all women's health providers in Nebraska

Medicare billing

Part B allowed, 2024
$903
Medicare patients
11
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol20$1,246

Paid to pharmacies, not to this prescriber.

Other women's health in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →